Sherko Kuemmel

Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer

Sherko Kuemmel, Joerg Heil, S. Bruz̆as et al. · JAMA Surgery · 2023 · 66 citations · Full text

Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany

Mattea Reinisch, S. Bruz̆as, Jennifer Spoenlein et al. · Therapeutic Advances in Medical Oncology · 2023 · 32 citations · Full text

Using the framework of corporate culture in “mergers” to support the development of a cultural basis for integrative medicine – guidance for building an integrative medicine department or service

Claudia M. Witt, Marion Pérard, Brian Berman et al. · Patient Preference and Adherence · 2015 · 21 citations · Full text

Olaparib for metastatic breast cancer in a patient with a germline PALB2 variant

Sherko Kuemmel, Hakima Harrach, Rita K. Schmutzler et al. · npj Breast Cancer · 2020 · 21 citations · Full text

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study

Sherko Kuemmel, Carlo Tondini, Jacinta Abraham et al. · Breast Cancer Research and Treatment · 2021 · 20 citations · Full text